TMG (Betaine Anhydrous).

Betaine and 5-methyltetrahydrofolate are the two methyl donors that can remethylate homocysteine to methionine. The routes run in parallel and cover for one another.

The folate-dependent remethylation step needs methylcobalamin, whereas the BHMT step betaine feeds is B12-independent. Betaine covers more of the pathway when cobalamin is limited.

Transsulfuration toward cysteine depends on two pyridoxal phosphate enzymes, giving homocysteine an exit rather than a recycle. Betaine recycles, B6 clears.

Choline is oxidised to betaine in mitochondria, so the two occupy the same pathway. Anhydrous betaine spares choline for its phospholipid and neurotransmitter roles.

After donating its methyl group betaine becomes dimethylglycine and is progressively demethylated to glycine. Glycine is where betaine's carbon ends up.

Betaine regenerates methionine, which is converted to S-adenosylmethionine for every methyltransferase in the body. The two sit one step apart on the same route.

Creatine's final synthesis step is one of the largest single consumers of S-adenosylmethionine, and betaine helps keep that donor pool filled. Both compounds also act as intracellular osmolytes in muscle.

BHMT is a zinc-dependent enzyme, using the metal to activate homocysteine's sulfur for methyl transfer. Without zinc the betaine route cannot run.

Riboflavin-derived FAD is the cofactor of MTHFR, the enzyme producing the methylfolate used by the other remethylation route. Its status sets how much falls to betaine.

Clearance of excess nicotinamide proceeds by methylation, consuming S-adenosylmethionine. Betaine replenishes the methyl pool that this clearance draws down.

Homocysteine can be recycled to methionine by betaine or committed to cysteine through transsulfuration, the pathway that ends in the residue NAC also supplies. The two act on the same junction from opposite directions.

Betaine hydrochloride and anhydrous betaine deliver the same betaine ion, so their doses are additive. The hydrochloride form is used for its acid load rather than for extra betaine.

Betaine donates a methyl group to homocysteine through betaine-homocysteine methyltransferase, and methionine is the direct product of that reaction. Supplemental methionine enters the same cycle downstream of where betaine acts. A high methionine load also raises homocysteine production, which is the setting in which betaine's remethylation capacity is studied.

The methionine that betaine generates only becomes a usable methyl donor once methionine adenosyltransferase converts it to S-adenosylmethionine, a reaction that requires ATP and magnesium. Without adequate magnesium that step is limited regardless of how much betaine is supplied. This is settled enzymology and needs no combination trial.

Carnitine is built in the body from lysine residues that must first be methylated three times by S-adenosylmethionine-dependent methyltransferases. Betaine supports SAM regeneration by feeding methionine back into the cycle. The connection is biosynthetic; it does not mean betaine raises carnitine levels in someone already replete.

Protein-bound lysine is the carbon skeleton of carnitine, and the first step of its conversion is trimethylation using S-adenosylmethionine. Betaine sits upstream of that methyl supply through the remethylation of homocysteine to methionine. Both are needed for the pathway to run and neither substitutes for the other.

Creatine synthesis begins when arginine donates its guanidino group to glycine, and finishes when guanidinoacetate methyltransferase adds a methyl group from S-adenosylmethionine. That final methylation is the single largest consumer of SAM in the body. Betaine's role is to keep that methyl supply regenerating, which is the mechanistic argument behind pairing it with creatine.

Phosphatidylcholine is the body's main choline reservoir, and choline is irreversibly oxidised to betaine in liver and kidney mitochondria. Supplying phosphatidylcholine therefore feeds the same methyl donor pool that betaine occupies directly. Conversely, adequate betaine spares choline for its phospholipid and acetylcholine roles rather than sending it down the oxidation route.

Alpha-glycerophosphocholine is a choline delivery form, and a portion of absorbed choline is oxidised to betaine rather than used for phospholipid or acetylcholine synthesis. Adequate betaine reduces the pull on choline for methylation. The two are linked through one irreversible conversion step.

Citicoline delivers choline plus cytidine, and choline oxidation to betaine is one of the fates of that delivered choline. Where betaine is supplied separately, more of the choline stays available for membrane phospholipid synthesis. The relationship is a branch point in choline handling, not an additive effect on any single endpoint.

Lecithin is a phosphatidylcholine-rich material and feeds the choline pool that partly converts to betaine. It contributes to methyl donor supply indirectly and slowly compared with betaine given as itself. Both end up at the same node of one-carbon metabolism.

Homocysteine has two fates: remethylation back to methionine, which betaine drives, or transsulfuration to cysteine and onward to glutathione and taurine. Pushing remethylation shifts the balance away from the transsulfuration branch. Supplemental taurine sits at the far end of that other branch, so the two occupy opposite exits from the same junction.

Cysteine is made from homocysteine through the transsulfuration branch, the alternative to the remethylation branch that betaine supports. Directing homocysteine back to methionine leaves less for cysteine synthesis. Supplying cysteine directly removes that competition, which is why the two are sometimes formulated together.

Glutathione synthesis draws on cysteine, which in turn comes partly from homocysteine through transsulfuration. Betaine pushes homocysteine the other way, toward methionine. The net effect on glutathione depends on cysteine supply from the diet and is not a simple additive relationship.

Betaine and myo-inositol are both organic osmolytes that cells accumulate to maintain volume under osmotic stress, particularly in the kidney medulla, and they are taken up by related sodium-dependent transporters. The two are partly interchangeable in that role. This is cell physiology rather than a measured supplement pairing.

Betaine is taken into cells by the sodium and chloride dependent transporter BGT1, so its cellular accumulation is tied to sodium gradients. This is the basis for the cell hydration framing used around betaine in training formulas. The transport chemistry is settled; the performance consequence is a separate and less settled question.

Bicarbonate acts as an extracellular buffer during high intensity work while betaine is studied for intracellular osmolyte and methylation effects. They are combined in performance formulas because the mechanisms do not overlap. No study has tested the two together and both carry their own gastrointestinal tolerance limits.

Beta-alanine raises muscle carnosine and buffers intracellular pH; betaine acts as an osmolyte and a methyl donor. The two appear in the same pre-workout formulas on non-overlapping mechanisms. The pairing is formulation convention and has not been measured as a combination.

Caffeine and betaine sit together in most pre-workout blends without any shared pathway, caffeine acting through adenosine receptor antagonism and betaine through osmolyte and methyl donor routes. Nothing about one changes the handling of the other. This is a formulation observation, not a mechanistic claim.

A large protein dose delivers methionine, and methionine catabolism generates homocysteine, which is exactly the substrate betaine remethylates. Higher protein intake therefore raises the demand on the remethylation pathways. This is standard amino acid metabolism and does not require a combination study to state.

Betaine-homocysteine methyltransferase is expressed chiefly in liver and kidney, so betaine's methyl donor work is largely hepatic, and silymarin is studied in the same organ. The two act by unrelated chemistry and are combined on that shared location. No combination data exists and neither is being described as acting on any condition.